Works matching DE "ELI Lilly %26 Co."
Results: 403
Lilly plans new clinical trial of Xigris.
- Published in:
- Nursing in Critical Care, 2007, v. 12, n. 3, p. 172, doi. 10.1111/j.1478-5153.2007.00220_6.x
- By:
- Publication type:
- Article
Ariad Pharmaceuticals Wins First Round Over Eli Lilly, Patents on Methods Can Be Far-reaching.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 15, p. 1028, doi. 10.1093/jnci/djj340
- By:
- Publication type:
- Article
Raloxifene Prevails in STAR Trial, May Face Easier Road to Acceptance Than Previous Drugs.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 11, p. 733, doi. 10.1093/jnci/djj253
- By:
- Publication type:
- Article
Injection Site Reactions in the Federal Adverse Event Reporting System (FAERS) Post-Marketing Database Vary Among Biologics Approved to Treat Moderate-To-Severe Psoriasis.
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 1, p. 99, doi. 10.1007/s13555-019-00341-2
- By:
- Publication type:
- Article
Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure.
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 1, p. 133, doi. 10.1007/s13555-019-00340-3
- By:
- Publication type:
- Article
Rapid Response of Biologic Treatments of Moderate-to-Severe Plaque Psoriasis: A Comprehensive Investigation Using Bayesian and Frequentist Network Meta-analyses.
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 1, p. 73, doi. 10.1007/s13555-019-00337-y
- By:
- Publication type:
- Article
Understanding Treatment Preferences in Patients with Moderate to Severe Plaque Psoriasis in the USA: Results from a Cross-Sectional Patient Survey.
- Published in:
- Dermatology & Therapy, 2019, v. 9, n. 4, p. 785, doi. 10.1007/s13555-019-00334-1
- By:
- Publication type:
- Article
THE MEN BEHIND THE EPONYMOUS PHARMACEUTICALS COMPANIES.
- Published in:
- Our Dermatology Online / Nasza Dermatologia Online, 2014, v. 5, n. 1, p. 92, doi. 10.7241/ourd.20141.25
- By:
- Publication type:
- Article
Theft of Pharmaceuticals in Brazil Governed by American Law.
- Published in:
- Defense Counsel Journal, 2006, v. 73, n. 2, p. 199
- By:
- Publication type:
- Article
Drug for Severe Sepsis Is Withdrawn From Market, Fails to Reduce Mortality.
- Published in:
- JAMA: Journal of the American Medical Association, 2011, v. 306, n. 22, p. 2439, doi. 10.1001/jama.2011.1755
- By:
- Publication type:
- Article
NEWS AND ADVANCES.
- Published in:
- Journal of Chinese Clinical Medicine, 2011, v. 6, n. 1, p. 1
- Publication type:
- Article
Lilly snaps up Alnara.
- Published in:
- Nature Biotechnology, 2010, v. 28, n. 9, p. 882, doi. 10.1038/nbt0910-882b
- By:
- Publication type:
- Article
DNA patents and diagnostics: not a pretty picture.
- Published in:
- Nature Biotechnology, 2010, v. 28, n. 8, p. 784, doi. 10.1038/nbt0810-784
- By:
- Publication type:
- Article
Lilly's free web screening.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 7, p. 584, doi. 10.1038/nbt0709-584
- By:
- Publication type:
- Article
Ariad's NFκB patent claims shot down on appeal.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 6, p. 494, doi. 10.1038/nbt0609-494b
- By:
- Publication type:
- Article
Giants wrestle over ImClone.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 12, p. 1323, doi. 10.1038/nbt1208-1323b
- By:
- Publication type:
- Article
Deaths stalk GLP-1 agonist.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 11, p. 1204, doi. 10.1038/nbt1108-1204b
- By:
- Publication type:
- Article
Myriad stumbles, Wyeth closes on Alzheimer's.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 8, p. 841, doi. 10.1038/nbt0808-841
- By:
- Publication type:
- Article
Inhaled insulin's last gasp?
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 5, p. 479, doi. 10.1038/nbt0508-479
- By:
- Publication type:
- Article
Biotech takes aim at large anti-estrogen markets.
- Published in:
- Nature Biotechnology, 2006, v. 24, n. 12, p. 1455, doi. 10.1038/nbt1206-1455
- By:
- Publication type:
- Article
Patently absurd?
- Published in:
- Nature Biotechnology, 2006, v. 24, n. 7, p. 737, doi. 10.1038/nbt0706-737
- By:
- Publication type:
- Article
A license to print money?
- Published in:
- Nature Biotechnology, 2006, v. 24, n. 6, p. 593, doi. 10.1038/nbt0606-593
- Publication type:
- Article
Is the viability of the Lilly doctrine on the decline?
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 8, p. 943, doi. 10.1038/nbt0803-943
- By:
- Publication type:
- Article
In Brief.
- Published in:
- Nature Biotechnology, 2001, v. 19, n. 12, p. 1095, doi. 10.1038/nbt1201-1095
- By:
- Publication type:
- Article
Analysts: Isis?Lilly deal validates antisense.
- Published in:
- Nature Biotechnology, 2001, v. 19, n. 10, p. 898, doi. 10.1038/nbt1001-898
- By:
- Publication type:
- Article
Chiral drugs viable, despite failure.
- Published in:
- Nature Biotechnology, 2000, v. 18, n. 12, p. 1239, doi. 10.1038/82335
- By:
- Publication type:
- Article
Protein C may be sepsis solution.
- Published in:
- Nature Biotechnology, 2000, v. 18, n. 9, p. 917, doi. 10.1038/79371
- By:
- Publication type:
- Article
Johnson & Johnson acquires Centocor.
- Published in:
- Nature Biotechnology, 1999, v. 17, n. 9, p. 844, doi. 10.1038/12826
- By:
- Publication type:
- Article
Hepatitis C collaboration.
- Published in:
- Nature Biotechnology, 1999, v. 17, n. 5, p. 409, doi. 10.1038/8537
- By:
- Publication type:
- Article
THE LEARNED INTERMEDIARY DOCTRINE IN NEW MEXICO: AN UNCERTAIN FUTURE.
- Published in:
- New Mexico Law Review, 2010, v. 40, n. 3, p. 299
- By:
- Publication type:
- Article
New drugs and dosage forms.
- Published in:
- 2010
- Publication type:
- Product Review
New drugs and dosage forms.
- Published in:
- 2009
- Publication type:
- Product Review
New drugs and dosage forms.
- Published in:
- 2009
- Publication type:
- Product Review
Antisense drugs progressing through product pipelines.
- Published in:
- American Journal of Health-System Pharmacy, 2002, v. 59, n. 21, p. 2046, doi. 10.1093/ajhp/59.21.2046
- Publication type:
- Article
ARIAD PHARMACEUTICALS, INC. V. ELI LILLYAND Co.
- Published in:
- Berkeley Technology Law Journal, 2011, v. 26, n. 1, p. 367
- Publication type:
- Article
Exhibitors Listing.
- Published in:
- 2015
- Publication type:
- Other
Exhibitor Listing.
- Published in:
- 2014
- Publication type:
- Other
Conference recap: Winning PR health care strategies.
- Published in:
- 2013
- Publication type:
- Proceeding
…As Lilly Shutters Singapore Discovery Center.
- Published in:
- Bio-IT World, 2010, v. 9, n. 6, p. 11
- By:
- Publication type:
- Article
Pharma's Early Cloud Adopters.
- Published in:
- Bio-IT World, 2009, v. 8, n. 6, p. 31
- By:
- Publication type:
- Article
Big Pharma's Road to Enlight(enment).
- Published in:
- Bio-IT World, 2008, v. 7, n. 7, p. 10
- Publication type:
- Article
Enlight's Model Starts Making Sense.
- Published in:
- 2008
- By:
- Publication type:
- Editorial
Project Summaries.
- Published in:
- Bio-IT World, 2008, v. 7, n. 6, p. 28
- Publication type:
- Article
Lilly Creates Standards for Technology Adoption.
- Published in:
- Bio-IT World, 2008, v. 7, n. 6, p. 21
- By:
- Publication type:
- Article
Bio·IT Word 2008 Best Practices.
- Published in:
- Bio-IT World, 2008, v. 7, n. 6, p. 18
- By:
- Publication type:
- Article
Lilly's Grid Goes Open Source.
- Published in:
- Bio-IT World, 2008, v. 7, n. 6, p. 16
- By:
- Publication type:
- Article
India Becoming Favored Destination for Clinical Trials.
- Published in:
- Bio-IT World, 2008, v. 7, n. 2, p. 33
- By:
- Publication type:
- Article
Jubilant Curries Favor With BioPharma.
- Published in:
- Bio-IT World, 2006, v. 5, n. 9, p. 20
- By:
- Publication type:
- Article
News Blast.
- Published in:
- Bio-IT World, 2005, v. 4, n. 9, p. 8
- Publication type:
- Article
De-Lovely Pharmaceuticals.
- Published in:
- Bio-IT World, 2004, v. 3, n. 11, p. 44
- By:
- Publication type:
- Article